Carl P. Sherr & Co., LLC Moderna, Inc. Transaction History

Carl P. Sherr & Co., LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$69.51 - $104.43 $16,334 - $24,541	-235 Reduced 7.17%	3,043 $302,000
Q3 2023 Nov 03, 2023	BUY	$96.41 - $126.61 $21,306 - $27,980	221 Added 7.23%	3,278 $338,000
Q2 2023 Jul 17, 2023	BUY	$118.5 - $160.53 $32,113 - $43,503	271 Added 9.73%	3,057 $371,000
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $61,182 - $88,856	-451 Reduced 13.93%	2,786 $427,000
Q4 2022 Feb 02, 2023	SELL	$118.38 - $210.04 $1,775 - $3,150	-15 Reduced 0.46%	3,237 $581,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $17,710 - $29,127	-150 Reduced 4.41%	3,252 $385,000
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $137,510 - $207,316	-1,174 Reduced 25.66%	3,402 $486,000
Q1 2022 May 03, 2022	SELL	$126.46 - $235.05 $40,340 - $74,980	-319 Reduced 6.52%	4,576 $788,000
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $154,912 - $252,797	-686 Reduced 12.29%	4,895 $1.24 Million
Q3 2021 Nov 03, 2021	SELL	$221.9 - $484.47 $2,884 - $6,298	-13 Reduced 0.23%	5,581 $2.15 Million
Q2 2021 Jul 21, 2021	BUY	$129.91 - $234.98 $34,426 - $62,269	265 Added 4.97%	5,594 $1.31 Million
Q1 2021 Apr 13, 2021	BUY	$109.18 - $185.98 $11,136 - $18,969	102 Added 1.95%	5,329 $698,000
Q4 2020 Feb 08, 2021	BUY	$65.74 - $169.86 $4,864 - $12,569	74 Added 1.44%	5,227 $546,000
Q3 2020 Oct 19, 2020	BUY	$54.34 - $94.85 $280,014 - $488,762	5,153 New	5,153 $365,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Carl P. Sherr & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Carl P. Sherr & Co., LLC with notifications on news.